Pfizer (PFE) and Valena Begin Phase 2 Study for Lyme Disease Vaccine Candidate

Go back to Pfizer (PFE) and Valena Begin Phase 2 Study for Lyme Disease Vaccine Candidate
Pfizer Inc. (NYSE: PFE) Delayed: 39.82 -0.04 (0.1%)
Previous Close $39.86    52 Week High $37.39 
Open $39.68    52 Week Low $28.25 
Day High $40.07    P/E 24.13 
Day Low $39.50    EPS $1.65 
Volume 10,967,944